Navigation Links
BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
Date:12/6/2007

BIAS Now One of a Select Group in North America with this Elevated Partner

Status

ATLANTA, Dec. 6 /PRNewswire/ -- BIAS Corporation, an Oracle System Integrator, today announced it has achieved Oracle Certified Advantage Partner status in the Oracle PartnerNetwork. To qualify for this level of membership - - the highest level in the Oracle PartnerNetwork -- BIAS had to demonstrate superior product knowledge with Oracle Technology and Applications, strong demonstration and implementation capabilities, and a high level of commitment and sponsorship to working with Oracle.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071204/BIASLOGO )

"Over the years, BIAS has proven time and again to be a valuable player in the Oracle consulting sector," said Oracle Vice President of Commercial Technology Sales, Dale Weideling. "BIAS has built its reputation on creating innovative solutions for our customers' business challenges, using both Oracle Technology and Oracle Applications. Their elevation to Certified Advantage Partner status is well-earned."

BIAS works closely with Oracle's Development, Support, and Sales organizations and has been instrumental in successfully implementing components of Oracle(R) Fusion Middleware for a number of customers and making contributions to the release of Oracle WebCenter. BIAS consultants and directors are active members of the Oracle Customer Advisory Boards and are regular presenters at Oracle Technology and Applications events around the United States.

"We're excited to take our relationship with Oracle to the next level. This new status will accelerate our strategic work together and continue to put us in a better position to serve the needs of our customers," said BIAS President Jeff Harvey, who along with Vice President John Ezzell founded the company.

"This is a huge honor and privilege for BIAS and our customers," added Mr. Ezzell. "Our consultants are the absolute best in the business and it is great when Oracle recognizes us for our achievements by promoting us to the ranks of Oracle's highest level of Oracle PartnerNetwork membership."

About BIAS

BIAS is a leading Oracle System Integrator and Software Reseller with expertise in Oracle E-Business Suite Applications, Oracle Database, Oracle Fusion Middleware, and Oracle Business Intelligence products. BIAS works hand-in-hand with Oracle's development, support, and sales teams to build and deploy high performance enterprise business solutions. For more information about BIAS, please email info@biascorp.com, or visit the company on the internet at http://www.biascorp.com.

About the Oracle PartnerNetwork

Oracle PartnerNetwork is a global business network of more than 19,500 companies who deliver innovative software solutions based on Oracle software. Through access to Oracle's premier products, education, technical services, marketing and sales support, the Oracle PartnerNetwork program provides partners with the resources they need to be successful in today's global economy. Oracle partners are able to offer their customers leading-edge solutions backed by Oracle's position as the world's largest enterprise software company. Partners who are able to demonstrate superior product knowledge, technical expertise and a commitment to doing business with Oracle qualify for the Certified Partner levels.

http://oraclepartnernetwork.oracle.com/

Trademarks

Oracle is a registered trademark of Oracle Corporation and/or its affiliates.

Contact: Melissa Hutchins

BIAS Corporation

770-352-0151

operations@biascorp.com


'/>"/>
SOURCE BIAS Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Pharsight Achieves First License Sale for Public-Source Database
2. GenoLogics Geneus Achieves GeneChip-compatible(TM) Status with the Affymetrix GeneChip(R) Microarray Platform
3. Sanofi Pasteurs Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage
4. Signalife Achieves $1.98 Million Sales Orders Thus Far
5. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
6. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
7. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
8. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
9. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
10. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
11. Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc ... with Compass Research . GGI's mission is to advance global health and highlight ... in need in honor of each clinical trial volunteer. The vision of GGI is ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017 /PRNewswire/ ... and Beyond Type 1, a not-for-profit advocacy and education ... announced a grant from Beyond Type 1 to support ... 1 and other insulin-requiring diabetes.  For ... stem cell-derived cell replacement therapies with a focus on ...
(Date:2/22/2017)... ANGELES, CA (PRWEB) , ... February 22, 2017 ... ... today announced that is has acquired Kendall Research Systems, LLC (KRS) ... Technology (MIT) that develops neural interface technology for research and clinical applications. The ...
Breaking Biology Technology:
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):